Abstract
Great improvement in the percutaneous treatment of obstructive coronary artery disease have been made over the past few decades. Recent developments have focused on alterations in stent design and the duration of dual antiplatelet therapy. The ReCre8 trial assessed clinical outcomes after implantation of the permanent polymer zotarolimus-eluting stent versus
... read more